Q4 2023 Holdings
Filed 2024-02-14 | 67 holdings | $336.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus NV | EQUITIES | N5749R100 | $17.8M | 645,581 | 5.3% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $14.9M | 6,420,136 | 4.4% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $14.4M | 500,042 | 4.3% |
| Nuvalent Inc(NUVL) | EQUITIES | 670703107 | $14.2M | 193,000 | 4.2% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $12.5M | 3,705,779 | 3.7% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $12.1M | 1,258,641 | 3.6% |
| Rocket Pharmaceuticals Inc(RCKT) | EQUITIES | 77313F106 | $11.5M | 382,672 | 3.4% |
| Medtronic PLC(MDT) | EQUITIES | G5960L103 | $11.1M | 135,000 | 3.3% |
| Sanofi SA(SNY) | EQUITIES | 80105N105 | $10.9M | 220,000 | 3.3% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $10.8M | 1,170,000 | 3.2% |
| Celldex Therapeutics Inc(CLDX) | EQUITIES | 15117B202 | $9.8M | 247,215 | 2.9% |
| Mirati Therapeutics Inc(MRTXEUR)Call | LONG OPTION CALLS | 60468T105 | $8.8M | 150,000 | 2.6% |
| Olema Pharmaceuticals Inc(OLMA) | EQUITIES | 68062P106 | $8.1M | 573,830 | 2.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | EQUITIES | 76243J105 | $8.0M | 174,248 | 2.4% |
| Urogen Pharma Ltd(URGN) | EQUITIES | M96088105 | $7.9M | 525,404 | 2.3% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $7.5M | 163,168 | 2.2% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $6.8M | 247,723 | 2.0% |
| Praxis Precision Medicines Inc(PRAX) | EQUITIES | 74006W207 | $6.3M | 283,841 | 1.9% |
| Akero Therapeutics Inc(AKRO) | EQUITIES | 00973Y108 | $5.8M | 249,254 | 1.7% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $5.8M | 318,524 | 1.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $5.7M | 80,000 | 1.7% |
| Cogent Biosciences Inc(COGT) | EQUITIES | 19240Q201 | $5.7M | 966,748 | 1.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | EQUITIES | 02083G100 | $5.7M | 297,789 | 1.7% |
| Gossamer Bio Inc(GOSS) | EQUITIES | 38341P102 | $5.6M | 6,130,268 | 1.7% |
| Intuitive Surgical Inc(ISRG) | EQUITIES | 46120E602 | $5.3M | 15,808 | 1.6% |
| Tela Bio Inc(TELA) | EQUITIES | 872381108 | $5.3M | 795,080 | 1.6% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $5.2M | 20,000 | 1.5% |
| CymaBay Therapeutics Inc(CBAYUSD) | EQUITIES | 23257D103 | $5.2M | 218,975 | 1.5% |
| Caribou Biosciences Inc(CRBU) | EQUITIES | 142038108 | $5.2M | 900,818 | 1.5% |
| Scholar Rock Holding Corp(SRRK) | EQUITIES | 80706P103 | $5.1M | 270,000 | 1.5% |
| Penumbra Inc(PEN) | EQUITIES | 70975L107 | $5.0M | 20,000 | 1.5% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $4.8M | 155,504 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | EQUITIES | 803607100 | $4.5M | 46,884 | 1.3% |
| DexCom Inc(DXCM) | EQUITIES | 252131107 | $3.8M | 31,000 | 1.1% |
| Solid Biosciences Inc(SLDB) | EQUITIES | 83422E204 | $3.7M | 594,855 | 1.1% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $3.6M | 16,360 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $3.4M | 516,999 | 1.0% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $3.2M | 1,499,851 | 1.0% |
| Kodiak Sciences Inc(KOD) | EQUITIES | 50015M109 | $3.0M | 1,000,000 | 0.9% |
| Biohaven Ltd(BHVN) | EQUITIES | G1110E107 | $3.0M | 70,695 | 0.9% |
| MoonLake Immunotherapeutics(MLTX) | EQUITIES | 61559X104 | $3.0M | 50,000 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | EQUITIES | 834203309 | $3.0M | 73,665 | 0.9% |
| Evogene Ltd(EVGN) | EQUITIES | M4119S104 | $2.6M | 3,100,000 | 0.8% |
| Mirum Pharmaceuticals Inc(MIRM) | EQUITIES | 604749101 | $2.4M | 80,811 | 0.7% |
| KalVista Pharmaceuticals Inc(KALV)Call | LONG OPTION CALLS | 483497103 | $2.2M | 180,400 | 0.7% |
| Zura Bio Ltd(ZURA) | EQUITIES | G9TY5A101 | $2.2M | 462,997 | 0.6% |
| Annexon Inc(ANNX) | EQUITIES | 03589W102 | $1.9M | 417,429 | 0.6% |
| Compugen Ltd(CGEN) | EQUITIES | M25722105 | $1.9M | 940,000 | 0.6% |
| argenx SE(ARGX) | EQUITIES | 04016X101 | $1.8M | 4,826 | 0.5% |
| 89bio Inc(ETNBGBP) | EQUITIES | 282559103 | $1.8M | 158,719 | 0.5% |